Press releaseGlobe Newswire
Black Hawk Acquisition
BKHAU · NASDAQ
$4.02+$1.02 (+34.00%)TodayMarket closed ·
No price history for this range.
Latest news
- Press releaseGlobe Newswire
Vesicor Therapeutics Appoints Michael Tolentino, M.D., as Chief Executive Officer
- Press releaseGlobe Newswire
Vesicor Therapeutics, Inc. and Black Hawk Acquisition Corporation Enter into a Business Combination Agreement to Create a Biotechnology Company Advancing p53-based Cancer Therapeutics Delivered Via Microvesicles
Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.